BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4550215)

  • 1. Prolongation of the lag phase of Mycobacterium leprae by dapsone.
    Levy L
    Proc Soc Exp Biol Med; 1972 Jan; 139(1):263-6. PubMed ID: 4550215
    [No Abstract]   [Full Text] [Related]  

  • 2. Susceptibility of strains of Mycobacterium leprae isolated prior to 1977 from patients with previously untreated lepromatous leprosy.
    Shepard CC; Rees RJ; Levy L; Pattyn SR; Baohong J; Dela Cruz EC
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):11-5. PubMed ID: 3519796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Some characteristics of the action of dapsone on multiplication of Mycobacterium leprae in the mouse.
    Levy L; Peters JH
    Lepr Rev; 1977 Dec; 48(4):237-45. PubMed ID: 400808
    [No Abstract]   [Full Text] [Related]  

  • 4. Bactericidal action of dapsone against Mycobacterium leprae in mice.
    Levy L
    Antimicrob Agents Chemother; 1976 Apr; 9(4):614-7. PubMed ID: 773300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dapsone-resistant leprosy in Jakarta: a preliminary report.
    Utji R; Kosasih A; Santoso AU
    Lepr Rev; 1983 Sep; 54(3):193-5. PubMed ID: 6355723
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on dapsone-resistant Mycobacterium leprae in leprosy patients of Gudiyatham Taluk, the leprosy control area of the Schieffelin Leprosy Research and Training Centre, Karigiri. 2. A progress report.
    Almeida JG; Christian M; Chacko CJ; Taylor PM; Fritschi EP
    Lepr Rev; 1983 Sep; 54(3):185-91. PubMed ID: 6355722
    [No Abstract]   [Full Text] [Related]  

  • 7. Dapsone-resistant Mycobacterium leprae in a patient receiving dapsone in low doses.
    Browne SG
    Int J Lepr Other Mycobact Dis; 1969; 37(3):296-301. PubMed ID: 4906048
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined clofazimine- and dapsone-resistant leprosy. A case report.
    Kar HK; Bhatia VN; Harikrishnan S
    Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dapsone-resistant leprosy in a population of Bamako (Mali).
    Baquillon G; Ferracci C; Saint Andre P; Pattyn SR
    Lepr Rev; 1980 Dec; 51(4):315-9. PubMed ID: 7012500
    [No Abstract]   [Full Text] [Related]  

  • 10. Bacteriology of Mycobacterium leprae.
    Pattyn SR
    Lepr Rev; 1983 Jun; Spec No():17-22. PubMed ID: 6193386
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary dapsone-resistant leprosy.
    Pearson JM; Haile GS; Rees RJ
    Lepr Rev; 1977 Jun; 48(2):129-32. PubMed ID: 330999
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro and in vivo experiments with the new inhibitor of mycobacterium leprae brodimoprim alone and in combination with dapsone.
    Seydel JK; Wempe EG; Rosenfeld M; Jagannathan R; Mahadevan PR; Dhople AM
    Arzneimittelforschung; 1990 Jan; 40(1):69-75. PubMed ID: 2187440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDS-resistant leprosy.
    Neelan PN; Reddy BN
    Int J Lepr Other Mycobact Dis; 1985 Mar; 53(1):115-8. PubMed ID: 3889186
    [No Abstract]   [Full Text] [Related]  

  • 14. Clofazimine therapy of lepromatous leprosy caused by dapsone-resistant mycobacterium leprae.
    Levy L; Shepard CC; Fasal P
    Am J Trop Med Hyg; 1972 May; 21(3):315-21. PubMed ID: 4554496
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence of secondary dapsone-resistant leprosy in Upper Volta.
    Pattyn SR; Yada A; Sansarricq H; van Loo L
    Lepr Rev; 1984 Dec; 55(4):361-7. PubMed ID: 6396476
    [No Abstract]   [Full Text] [Related]  

  • 16. Viability of Myco. leprae in the skin and bone marrow of patients with lepromatous leprosy while on dapsone or lamprene.
    Karat AB
    Lepr Rev; 1975 Jun; 46(2 Suppl):69-72. PubMed ID: 1100966
    [No Abstract]   [Full Text] [Related]  

  • 17. Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy.
    Cambau E; Carthagena L; Chauffour A; Ji B; Jarlier V
    Clin Infect Dis; 2006 Jan; 42(2):238-41. PubMed ID: 16355335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary dapsone-resistant leprosy in Cebu, Philippines.
    Guinto RS; Cellona RV; Fajardo TT; de la Cruz EC
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):427-30. PubMed ID: 7042607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survey for primary dapsone resistance in Cuba.
    Gonzalez AB; Hernandez O; Suarez O; Gonzalez-Abreu E; Rodriguez JE
    Lepr Rev; 1986 Dec; 57(4):341-5. PubMed ID: 3540496
    [No Abstract]   [Full Text] [Related]  

  • 20. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
    Matsuoka M; Kashiwabara Y; Namisato M
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):452-5. PubMed ID: 11332288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.